Ristigo (Rosanalyxizumab noli) on Bigfoot Society

Bigfoot SocietyAugust 10, 2026

Hidden Bigfoot Archives Reveal Southwest Secrets in New Mexico & Oklahoma | Archives

1:05
pre-roll
Jeremiah Byron
Speaker
Jeremiah Byron
August 10, 2026
Announcer-readDirect responseBaked-in adHealth & Wellness
0:00 / 1:05
@ in ep

Transcript

This is Lauren Vogelbaum from BrainStuff, and this episode is brought to you by Ristigo. Are you struggling with the symptoms of generalized myasthenia gravis or GMG, a rare disease that can make every day feel unpredictable? There is a targeted treatment option that may help called Ristigo or Rosanalyxizumab noli, the first FDA-approved targeted treatment for adults with either anti-ACHR or anti-Musk antibody-positive GMG. Ristigo may cause serious side effects, including infection, aseptic meningitis, and/or hypersensitivity reactions. Tell your doctor right away if you have signs or symptoms of an infection, meningitis, or any other undesirable reactions. Administration of live or live attenuated vaccines is not recommended during treatment. The most common side effects include headache, infections, diarrhea, fever, hypersensitivity reactions, and nausea. If you're living with GMG, ask your doctor about Ristigo. For more information, call 1-844-599-2273 or visit rystiggo.com.

Auto-transcribed · verbatim audio matches · Report an error

Estimated ad cost

~$220range $32$1,500

Estimate of what a similar one-episode podcast ad would cost based on rank, placement, and duration

Methodology and limitations →

Ristigo (Rosanalyxizumab noli) sponsor landing page on Bigfoot Society

Ristigo (Rosanalyxizumab noli) sponsor landing page advertised on Bigfoot Society

Ristigo (Rosanalyxizumab noli) landing page captured for its sponsorship on Bigfoot Society.

rystiggo.com/

Episode

Bigfoot Society
Hidden Bigfoot Archives Reveal Southwest Secrets in New Mexico & Oklahoma | Archives
Host: Jeremiah Byron
Publisher: Jeremiah Byron